Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
about
Abundant Rodent Furan-Derived Urinary Metabolites Are Associated with Tobacco Smoke Exposure in Humans.Nicotine chemistry, metabolism, kinetics and biomarkersNicotine: Carcinogenicity and Effects on Response to Cancer Treatment - A ReviewUrinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approachBiomarkers of Tobacco Exposure: Summary of an FDA-sponsored Public WorkshopGene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival.Effect of cigarette smoking on urinary 2-hydroxypropylmercapturic acid, a metabolite of propylene oxide.Clinical trials methods for evaluation of potential reduced exposure productsNicotine metabolism in African Americans and European Americans: variation in glucuronidation by ethnicity and UGT2B10 haplotype.Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.Tobacco smoke exposure in nonsmoking hospitality workers before and after a state smoking ban.Sex differences in response to reduced nicotine content cigarettes.Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokersUGT2B10 genotype influences nicotine glucuronidation, oxidation, and consumption.Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention.Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial.Smokeless tobacco reduction with the nicotine lozenge and behavioral intervention.Measurement of smoking behavior: Comparison of self-reports, returned cigarette butts, and toxicant levels.1,3-Butadiene exposure and metabolism among Japanese American, Native Hawaiian, and White smokers.Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smokingEvidence supporting product standards for carcinogens in smokeless tobacco products.Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy productsCytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer.Grape seed proanthocyanidin suppression of breast cell carcinogenesis induced by chronic exposure to combined 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene.The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometryUrinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers.Smoking behaviour and toxin exposure during six weeks use of a potential reduced exposure product: Omni.Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis.Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers.2'-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor.Self-reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer.Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012.Exposure to a tobacco-specific lung carcinogen in adolescent versus adult smokersSalivary Thiocyanate, Uric Acid and pH as Biomarkers of Periodontal Disease in Tobacco Users and Non-Users- An In-Vitro StudyEffect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes.
P2860
Q24170376-CF36B8F3-3745-4CF2-BA10-03D7DEECB3D5Q24632647-CBF6A7AD-5687-4F9A-B6EC-8A5470D9EEC7Q26784043-28634F84-58BE-42B0-9CA4-06DCED87DF99Q28662000-D3CE2927-897C-4985-8C88-6434D2F0CA55Q29248704-924C23E5-32D3-4697-85E8-C6D260578B10Q33320978-0472DCC4-91E0-4F0A-AABF-498E699DA12AQ33461006-A70B7793-12C8-4374-8DDD-8CB1DB74088AQ33562506-41A315F8-2FBF-41DD-ACC5-77AFE0A433C3Q33574895-1B9E1584-BC7F-47AC-BFF8-70AA1A4B1FD9Q33583823-77F018EB-29D5-42DD-8B2B-125CE008594BQ33807979-49744199-7831-489D-B132-B97AA5643D8AQ33855129-F03245FE-129C-40FA-8F61-D8C9E01FB09DQ33857125-29394354-4EAC-46BF-8E82-8AF52B50BEE1Q33903103-5A880888-61A9-4D1B-84B9-F3577DA6C9B2Q33936367-4E06A384-AEF6-46BA-BF2B-909FEADCFD47Q33949619-230DA36A-3B88-44B9-81D5-98F0D1ABF651Q34023509-4BD3E747-7949-44E2-ABB2-727E6ABB6109Q34047090-578821D6-E787-48DF-A392-506C999379F6Q34452819-9F132B6C-9109-4C7F-869D-B6E56718D759Q34556938-37318D4A-EC68-493D-AA27-762FE5745A56Q34608572-3ABEC2DA-1CDD-464E-94F3-1D4C137BE15EQ34987618-D2802BB9-9338-4962-9FF4-2CFE06E27B07Q35008757-DFA476DD-AFA7-4778-9054-3B0B01D07857Q35011165-49D5DEC3-76D6-46D0-9FA0-1A26D1C380C4Q35154336-61C40C45-B084-45CC-8FAF-70624F6CF92FQ35175672-61F74623-9EC3-45CC-8B72-78481B56BE61Q35198490-FD040CD3-4A58-4FA9-B300-63C9AD347612Q35452161-DBB5AAC0-8734-4B52-9524-AF0C7FFB6742Q35538918-C6BDFF8F-7131-4A7E-A4F5-016278C80D56Q35638655-9DC9FC21-2551-4F0F-973C-3E900854AA36Q35747346-B50008A3-672C-4A29-A1FB-66F754824F5BQ35785036-5AC0C7B6-9769-4401-934C-5A78378CCA94Q35815009-5C68319C-C0E6-4B18-B6AF-067E0ACC8051Q35883271-D4FEC1D8-5850-4D15-8031-C571E4143C7AQ35904621-2E13BA00-CC72-431D-A7E6-E5AF5E277B74Q35990500-5A43053E-9EBF-4FFD-8A6E-8C8FBCEA9A33Q36002368-068459BE-82E6-49E5-B8FC-247C99A53863Q36047534-A038F844-348F-42B7-8015-AC756D3EBF73Q36047601-5D65ECF8-49CD-4847-88F4-84762785BD38Q36073330-3743EC9B-F631-4498-931F-2095D989AB14
P2860
Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Quantitation of urinary metabo ...... nogen after smoking cessation.
@en
Quantitation of urinary metabo ...... nogen after smoking cessation.
@nl
type
label
Quantitation of urinary metabo ...... nogen after smoking cessation.
@en
Quantitation of urinary metabo ...... nogen after smoking cessation.
@nl
prefLabel
Quantitation of urinary metabo ...... nogen after smoking cessation.
@en
Quantitation of urinary metabo ...... nogen after smoking cessation.
@nl
P2093
P1433
P1476
Quantitation of urinary metabo ...... nogen after smoking cessation.
@en
P2093
A T Miller
C L Zimmerman
D K Hatsukami
J A Jensen
J F Dor Koch
S E Murphy
S G Carmella
P304
P407
P577
1999-02-01T00:00:00Z